Product Description
Capecitabine Tablets are an extraordinary and in-demand treatment option, acclaimed for their triumphant effectiveness in combating colorectal and breast cancers. Available in customizable strengths of 150 mg and 500 mg, these lustrous, light peach, film-coated tablets are conveniently packaged in boxes of 10, 30, or 120 tablets, depending on manufacturer preference. Offered at a reduced price without compromising quality, Capecitabine is strictly prescription-only and is not suitable for patients with known DPD deficiency. These tablets are manufactured by various reputable pharmaceutical companies and are approved for use in several countries, including India and the US (as Xeloda). Reliable and odorless, they feature a 24-month shelf life and must be stored below 25C, ensuring safety and efficacy throughout their usage period in chemotherapy regimens.
Key Features and Specialized Use
Capecitabine Tablets are a formidable oral cytotoxic agent recommended for chemotherapy, primarily addressing colorectal and breast cancer. Featuring machine-assisted precision in formulation, these tablets stand out with a lustrous film-coating, reliable potency, and consistent performance. Suitable only for prescription use, the products use type is strictly clinical, requiring administration within 30 minutes after a meal. The tablets, being odorless and convenient, offer superior patient compliance and are crafted for trusted effectiveness by highly skilled pharmaceutical manufacturers.
Sample Availability, Packaging, and Supply Options
Capecitabine Tablets are readily supplied to fulfill varying healthcare demands. Samples are made available upon request to assist distributors, exporters, and healthcare professionals in quality assessment. Packaging details ensure hygiene and protection from moisture, offered in boxes containing 10, 30, or 120 tablets. Rate considerations reflect a reduced price without compromising quality. Supply is prompt and reliable, with payment terms flexible to meet the requirements of traders, wholesalers, and institutional buyers worldwide.
FAQs of Capecitabine Tablets:
Q: How should Capecitabine Tablets be administered for optimal effect?
A: Capecitabine Tablets must be taken with water within 30 minutes after a meal, as prescribed by a medical professional, to maximize absorption and effectiveness during chemotherapy treatments.
Q: What types of cancer are Capecitabine Tablets indicated for?
A: These tablets are primarily indicated for the treatment of colorectal cancer and breast cancer, acting as an antineoplastic agent within combination or standalone chemotherapy regimens.
Q: Where are Capecitabine Tablets approved for use?
A: Capecitabine Tablets are approved for cancer treatment in several countries, including India and the United States (where it is marketed as Xeloda), as well as other nations with regulatory endorsements.
Q: What precautions must be taken before using Capecitabine Tablets?
A: Patients known to have dihydropyrimidine dehydrogenase (DPD) deficiency must not use Capecitabine Tablets, as this predisposes them to severe side effects. Always consult a healthcare professional before use.
Q: When is the best time to take Capecitabine Tablets?
A: The tablets should be taken strictly within 30 minutes after finishing a meal to support optimal drug absorption and reduced gastrointestinal side effects.
Q: How should Capecitabine Tablets be stored to maintain their efficacy?
A: For best results, keep the tablets in a tightly closed container, store them below 25C, and ensure they are protected from moisture throughout their 24-month shelf life.